Schedule 13G ownership disclosure

BIORA THERAPEUTICS, INC.

Common Stock, par value $0.001 · CUSIP: 74319F404

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • M.H. Davidson & Co.

    Shares: 25,624.00 · Class: 0.56%

  • Davidson Kempner Arbitrage, Equities and Relative Value LP

    Shares: 880,603.00 · Class: 9.90%

  • Davidson Kempner Capital Management LP

    Shares: 906,227.00 · Class: 9.90%

  • Anthony A. Yoseloff

    Shares: 906,227.00 · Class: 9.90%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003345
Form type
SCHEDULE 13G/A
Filer
BIORA THERAPEUTICS, INC.
CIK
CIK 1580063
Filed
Aug 04, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub